TRIM69: a marker of metastasis and potential sensitizer to 5-Fluorouracil and PD-1 blockers in colon adenocarcinoma

• Published in: BMC gastroenterology Vol. 23; no. 1; pp. 1 - 292
• Main Authors: Chi, Xiao-Jv, Song, Yi-Bei, Liu, Deng-He, Wei, Li-Qiang, Zhao, An-Ran, An, Xin, Feng, Zi-Zhen, Lan, Xiao-Hua, Lv, Yu-Meng, Li, Hong-jun, Lan, Dong, He, Hui-Min
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 31.08.2023; BioMed Central; BMC
• Subjects: 5-Fluorouracil; Adenocarcinoma; Analysis; Apoptosis; Cancer therapies; Care and treatment; Cell death; COAD; Colon; Colon cancer; Colorectal cancer; Colorectal carcinoma; Diagnosis; Dosage and administration; Drug therapy; Ethanol; Fluorouracil; Gastroenterology; Gene expression; Genes; Genetic aspects; Genomes; Genomics; Health aspects; Metastases; Metastasis; mRNA; NOD-like signaling pathway; PD-1 blockers; PD-1 protein; Proteins; Signal transduction; Statistical significance; Survival analysis; TRIM69; Tumors; Variance analysis; China
• ISSN: 1471-230X; 1471-230X
• DOI: 10.1186/s12876-023-02927-9

Abstract Background Several proteins in the tripartite-motif (TRIM) family are associated with the development of colorectal cancer (CRC), but research on the role of TRIM69 was lacking. The present study examined the correlation between TRIM69 expression and colon adenocarcinoma (COAD). Methods mRNA sequencing data for COAD patients was extracted from The Cancer Genome Atlas to analyze correlations between TRIM69 expression and patients’ clinical features as well as survival. Potential associations with immune cells and chemosensitivity also were predicted using various algorithms in the TIMER, Limma, clusterProfiler, GeneMANIA, and Gene Set Cancer Analysis platforms. Subsequently, polymerase chain reaction analysis and immunohistochemical staining were used to detect TRIM69 expression in COAD tissue samples from real-world patients. Results TRIM69 expression was lower in COAD tissues than in normal tissues and correlated with the pathologic stage and metastasis (M category). Additionally, TRIM69 was found to be involved in several immune-related pathways, notably the NOD-like signaling pathway. These results suggest that high TRIM69 expression has the potential to enhance tumor sensitivity to 5-fluorouracil and programmed cell death protein 1 (PD-1) blockers. Conclusions From our findings that TRIM69 expression was significantly reduced in COAD compared with non-cancer tissues and associated with pathologic stage and metastasis, we conclude that increasing TRIM69 expression and/or activity may help to improve therapeutic outcomes. Accordingly, TRIM69 represents a potentially valuable marker of metastasis and target for adjuvant therapy in COAD.